208 related articles for article (PubMed ID: 37545022)
1. Renin-Angiotensin-Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease.
Murphy DP; Wolfson J; Reule S; Johansen KL; Ishani A; Drawz PE
J Am Soc Nephrol; 2023 Oct; 34(10):1721-1732. PubMed ID: 37545022
[TBL] [Abstract][Full Text] [Related]
2. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
[TBL] [Abstract][Full Text] [Related]
3. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.
Whitlock R; Leon SJ; Manacsa H; Askin N; Rigatto C; Fatoba ST; Farag YMK; Tangri N
Nephrol Dial Transplant; 2023 Oct; 38(11):2503-2516. PubMed ID: 37309038
[TBL] [Abstract][Full Text] [Related]
4. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
Brar S; Ye F; James MT; Hemmelgarn B; Klarenbach S; Pannu N;
JAMA Intern Med; 2018 Dec; 178(12):1681-1690. PubMed ID: 30422153
[TBL] [Abstract][Full Text] [Related]
5. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM; Bhaskaran K; van Diepen M; Carrero JJ; Nitsch D; Tomlinson LA
BMC Med; 2020 Jul; 18(1):195. PubMed ID: 32723383
[TBL] [Abstract][Full Text] [Related]
6. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.
Derington CG; Cohen JB; Mohanty AF; Greene TH; Cook J; Ying J; Wei G; Herrick JS; Stevens VW; Jones BE; Wang L; Zheutlin AR; South AM; Hanff TC; Smith SM; Cooper-DeHoff RM; King JB; Alexander GC; Berlowitz DR; Ahmad FS; Penrod MJ; Hess R; Conroy MB; Fang JC; Rubin MA; Beddhu S; Cheung AK; Xian W; Weintraub WS; Bress AP
PLoS One; 2021; 16(4):e0248080. PubMed ID: 33891615
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
9. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
10. Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis.
Shah M; Jain AK; Brunelli SM; Coca SG; Devereaux PJ; James MT; Luo J; Molnar AO; Mrkobrada M; Pannu N; Parikh CR; Paterson M; Shariff S; Wald R; Walsh M; Whitlock R; Wijeysundera DN; Garg AX
BMC Nephrol; 2014 Apr; 15():53. PubMed ID: 24694072
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease.
Walther CP; Winkelmayer WC; Richardson PA; Virani SS; Navaneethan SD
Nephrol Dial Transplant; 2021 Sep; 36(10):1893-1899. PubMed ID: 33367872
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease.
An J; Niu F; Sim JJ
Pharmacotherapy; 2021 Dec; 41(12):998-1008. PubMed ID: 34655484
[TBL] [Abstract][Full Text] [Related]
13. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis.
Du YH; Guan CJ; Li LY; Gan P
Ann Palliat Med; 2022 Mar; 11(3):1093-1101. PubMed ID: 35365039
[TBL] [Abstract][Full Text] [Related]
15. Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure.
Soler MJ; Noordzij M; Abramowicz D; de Arriba G; Basile C; van Buren M; Covic A; Crespo M; Duivenvoorden R; Massy ZA; Ortiz A; Sanchez JE; Petridou E; Stevens K; White C; Vart P; Gansevoort RT;
Clin J Am Soc Nephrol; 2021 Jul; 16(7):1061-1072. PubMed ID: 34088718
[TBL] [Abstract][Full Text] [Related]
16. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
Mayyas F; Bataineh W; Jarab A
Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
[TBL] [Abstract][Full Text] [Related]
17. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.
Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M;
Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery.
Yang SY; Huang TM; Lai TS; Chou NK; Tsao CH; Huang YP; Lin SL; Chen YM; Wu VC; Nsarf Study Group
Front Pharmacol; 2021; 12():662301. PubMed ID: 33967804
[No Abstract] [Full Text] [Related]
19. Aldosterone antagonists for preventing the progression of chronic kidney disease.
Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis.
Chen JY; Tsai IJ; Pan HC; Liao HW; Neyra JA; Wu VC; Chueh JS
Front Pharmacol; 2021; 12():665250. PubMed ID: 34354583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
